These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7746237)

  • 21. Pharmacokinetics and pharmacodynamics of intravenous acetaminophen in neonates.
    Allegaert K; van den Anker J
    Expert Rev Clin Pharmacol; 2011 Nov; 4(6):713-8. PubMed ID: 22111857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucuronidation in therapeutic drug monitoring.
    Shipkova M; Wieland E
    Clin Chim Acta; 2005 Aug; 358(1-2):2-23. PubMed ID: 15893300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Issues in therapeutic drug monitoring evaluation].
    Paintaud G; Le Guellec C; Furet Y; Autret-Leca E
    Therapie; 2001; 56(3):245-9. PubMed ID: 11475802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Value of therapeutic drug monitoring in epilepsy.
    Johannessen SI; Landmark CJ
    Expert Rev Neurother; 2008 Jun; 8(6):929-39. PubMed ID: 18505358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic drug monitoring principles in the neonate. National Academy of CLinical Biochemistry.
    Koren G
    Clin Chem; 1997 Jan; 43(1):222-7. PubMed ID: 8990257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical pharmacology and therapeutic drug monitoring in neonates and children.
    Loebstein R; Koren G
    Pediatr Rev; 1998 Dec; 19(12):423-8. PubMed ID: 9849072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic Drug Monitoring in Neonates: What Makes them Unique?
    Mian P; Flint RB; Tibboel D; van den Anker JN; Allegaert K; Koch BCP
    Curr Pharm Des; 2017; 23(38):5790-5800. PubMed ID: 28950825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic drug monitoring of cancer chemotherapy.
    Alnaim L
    J Oncol Pharm Pract; 2007 Dec; 13(4):207-21. PubMed ID: 18045780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medication monitoring in the elderly.
    Fowler JB
    Clin Lab Sci; 1995; 8(1):34-8. PubMed ID: 10150465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference.
    Wallemacq P; Armstrong VW; Brunet M; Haufroid V; Holt DW; Johnston A; Kuypers D; Le Meur Y; Marquet P; Oellerich M; Thervet E; Toenshoff B; Undre N; Weber LT; Westley IS; Mourad M
    Ther Drug Monit; 2009 Apr; 31(2):139-52. PubMed ID: 19177031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of liver and renal dysfunction on the pharmacokinetics of sedatives and analgesics in the critically ill patient.
    Yogaratnam D; Miller MA; Smith BS
    Crit Care Nurs Clin North Am; 2005 Sep; 17(3):245-50. PubMed ID: 16115532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Individualized monitoring of the therapy with gentamycin using pharmacokinetic methods. Which method to choose?].
    Carvalho A; Fonseca C; Falcão F; Pereira TA; Freitas O; Parrinha A; Costa M; Rodrigues MJ; Ceia F; Luís AS
    Acta Med Port; 1996; 9(7-9):187-95. PubMed ID: 9005695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suggestions for Model-Informed Precision Dosing to Optimize Neonatal Drug Therapy.
    Euteneuer JC; Kamatkar S; Fukuda T; Vinks AA; Akinbi HT
    J Clin Pharmacol; 2019 Feb; 59(2):168-176. PubMed ID: 30204236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Criteria supporting the study of drugs in the newborn.
    Ward RM; Benitz WE; Benjamin DK; Blackmon L; Giacoia GP; Hudak M; Lasky T; Rodriguez W; Selen A
    Clin Ther; 2006 Sep; 28(9):1385-98. PubMed ID: 17062311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ethical principles and parental choice: treatment options for neonates with hypoplastic left heart syndrome.
    Zeigler VL
    Pediatr Nurs; 2003; 29(1):65-9. PubMed ID: 12630511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic drug monitoring of phenytoin in critically ill patients.
    von Winckelmann SL; Spriet I; Willems L
    Pharmacotherapy; 2008 Nov; 28(11):1391-400. PubMed ID: 18956999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A primer on pharmacokinetics.
    Quan DJ
    Nephrol Nurs J; 2008; 35(2):213-5. PubMed ID: 18472692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Role of clinical pharmacology in the monitoring of therapy of HIV-infected subjects].
    Villani P; Cocchi L; Giacchino R; Seminari E; Regazzi MB; Maserati R
    Clin Ter; 1996 Jun; 147(6):279-93. PubMed ID: 8925637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Population pharmacokinetics and dosing of flucloxacillin in preterm and term neonates.
    Pullen J; de Rozario L; Stolk LM; Degraeuwe PL; van Tiel FH; Zimmermann LJ
    Ther Drug Monit; 2006 Jun; 28(3):351-8. PubMed ID: 16778719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pharmacokinetic studies in neonatology: regulatory and methodologic problems].
    Le Guellec C; Autret-Leca E; Odoul F; Jonville Béra AP; Paintaud G
    Therapie; 2001; 56(6):663-8. PubMed ID: 11878088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.